Venmax Drugs & Pharmaceuticals Ltd Financial Ratios
VENMAX · Healthcare · Current price ₹16.65
P/E ratio
79.7x
P/B ratio
1.4x
ROE
-0.2%
ROCE
5.3%
Debt / Equity
0.02
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 79.7x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.4x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -0.2% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 5.3% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.02 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Venmax Drugs & Pharmaceuticals Ltd's latest numbers.
Venmax Drugs & Pharmaceuticals Ltd profitability
Venmax Drugs & Pharmaceuticals Ltd generates a return on equity of -0.2% and a return on capital employed of 5.3%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.02 and a P/E of 79.7x, Venmax Drugs & Pharmaceuticals Ltd is conservatively financed. Our overall business-quality score for the company is 2.2 / 10.
Understand the ratios
More on Venmax Drugs & Pharmaceuticals Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.